Source: International Urology Nephrology. Unidade: FM
Subjects: GLOMERUNEFRITE, TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, Igor Denizarde Bacelar et al. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation. International Urology Nephrology, v. 46, n. 10, p. 2053-2054, 2014Tradução . . Disponível em: https://doi.org/10.1007/s11255-014-0792-0. Acesso em: 09 out. 2024.APA
Marques, I. D. B., Ramalho, J., David, D. R., Nahas, W. C., & David-Neto, E. (2014). Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation. International Urology Nephrology, 46( 10), 2053-2054. doi:10.1007/s11255-014-0792-0NLM
Marques IDB, Ramalho J, David DR, Nahas WC, David-Neto E. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation [Internet]. International Urology Nephrology. 2014 ; 46( 10): 2053-2054.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s11255-014-0792-0Vancouver
Marques IDB, Ramalho J, David DR, Nahas WC, David-Neto E. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation [Internet]. International Urology Nephrology. 2014 ; 46( 10): 2053-2054.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s11255-014-0792-0
